P

Inventor

CHAPPEL SCOTT C

US19 patents
⚠️ This page may combine multiple inventors who share the name “CHAPPEL SCOTT C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

APPLIED RESEARCH SYSTEMS

12 patents
US5272071ADec 21, 1993

Method for the modification of the expression characteristics of an endogenous gene of a given cell line

APPLIED RESEARCH SYSTEMS563 citations98
US6194177B1Feb 27, 2001

DNA encoding a hybrid heterodimeric protein

APPLIED RESEARCH SYSTEMS27 citations92
US6193972B1Feb 27, 2001

Hybrid heterodimeric protein hormone

APPLIED RESEARCH SYSTEMS17 citations92
US5260421ANov 9, 1993

Site-directed mutagenesis modified glycoprotein hormones

APPLIED RESEARCH SYSTEMS27 citations91
US5087615AFeb 11, 1992

Novel method of ovulation induction in humans

APPLIED RESEARCH SYSTEMS17 citations82
US6348444B1Feb 19, 2002

Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans

APPLIED RESEARCH SYSTEMS8 citations73
US5262518ANov 16, 1993

Ovulation kit comprising FSH isoforms with varying half-lives

APPLIED RESEARCH SYSTEMS5 citations73
US5986068ANov 16, 1999

Site-directed mutagenesis modified glycoprotein hormones and methods of use

APPLIED RESEARCH SYSTEMS6 citations72
US5352779AOct 4, 1994

Site-directed mutagenesis modified DNA encoding glycoprotein hormones and methods of use

APPLIED RESEARCH SYSTEMS4 citations61
US6663867B2Dec 16, 2003

Hybrid heterodimeric protein hormone comprising a TNF binding protein and a glycoprotein hormone subunit and method of using same

APPLIED RESEARCH SYSTEMS0 citations51
US5705479AJan 6, 1998

Site-directed mutagenesis modified glycoprotein hormones and methods of use

APPLIED RESEARCH SYSTEMS0 citations50
US5635475AJun 3, 1997

Site-directed mutagenesis modified glycoprotein hormones and methods of use

APPLIED RESEARCH SYSTEMS1 citations50

GENZYME CORP

4 patents

DIACRIN INC

2 patents

SERONO LAB

1 patent